Keysha Brooks-Coley Discusses Project to Address Health Equity and Disparities for Minority Patients

Video

The American Cancer Society Cancer Action Network partnered with the National Comprehensive Cancer Network and the National Minority Quality Forum to produce recommendations addressing issues regarding health equity and disparities among minority patients with cancer.

CancerNetwork® recently spoke with Keysha Brooks-Coley, vice president for federal advocacy and strategic alliances at the American Cancer Society Cancer Action Network (ACS CAN), regarding the Elevating Cancer Equity Project.

The project is a collaboration with the National Comprehensive Cancer Network (NCCN) and the National Minority Quality Forum (NMQF), focusing on addressing health equity and health disparity issues in minority communities.

“We know that minority communities often times don’t have access to coverage, don’t have access to life-saving screenings, prevention, and access to treatment because of insurance status, for example,” explained Coley-Brooks. “We have been working on many of those issues for many, many years and continue to [do so]. Last year we saw an opportunity to work with other partner organizations and really lean in even more on health disparities and looking at guideline-adherent care for individuals of diverse backgrounds.”

ACS CAN is the advocacy arm of the American Cancer Society, which works to prevent cancer, seek new treatments and cures for cancer, and ensure all patients have access to quality life-saving cancer care.

This segment comes from the CancerNetwork® portion of the MJH Life Sciences™ Medical World News®, airing daily on all MJH Life Sciences™ channels.

Recent Videos
6371178759112
Collaboration among different medical and research institutions may help improve quality of care for patients with cancer exposed to climate disasters.
Given resource scarcity, developing practice strategies for resource-constrained settings would require aid from commercial and government stakeholders.
According to Megan Mullins, PhD, MPH, challenging cultural norms surrounding death and dying may reduce the receipt of low-value end-of-life cancer care.
Earlier and more frequent talks about disabling ICDs with patients receiving end-of-life care and their families may help avoid excessive pain.
Related Content